Peptides are smaller versions of proteins. They may provide pro-aging support, anti-inflammatory, or muscle-building properties. However, more research is still necessary to understand their risks ...

Delytact (teserpaturev) is a genetically engineered oncolytic herpes simplex virus type 1 (HSV-1) that was approved for marketing in Japan earlier this year, and received pricing approval in ...

Buoyed by advancements in formulation technologies such as permeation enhancers, nanoparticle encapsulation and structural modification abilities, oral delivery and bioavailability of peptide ...

DelveInsight’s Head and Neck Cancer pipeline report depicts a robust space with 80+ active players working to develop 100+ ...

Supramolecular nanocatalysts, composed of peptides, chemicals and/or biogenic inorganics, mimic enzymes and offer affordable, precise medicines of the future. This Review explores their role in ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, will present new data from Cohort 1 of the GOBLET study at the 2025 ...

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.